Skip to content

HFOV With Intermittent Sigh Breaths in Neonate: Carbon Dioxide Level

High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths in Neonate: Effect on Carbon Dioxide Level

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05682937
Acronym
SighCO2
Enrollment
30
Registered
2023-01-12
Start date
2023-01-12
Completion date
2024-03-31
Last updated
2025-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-Frequency Ventilation

Keywords

Carbon Dioxide, High-Frequency Ventilation, Sigh Breath, Newborn

Brief summary

The goal of this clinical trial is to the short-term effects of sigh breaths during High-frequency oscillatory ventilation (HFOV) in neonate undergoing mechanical ventilation. From meta-analysis, It revealed HFOV in neonates could reduce chronic lung disease or death rather than conventional ventilation. The main question it aims to answer is: Do sigh breaths augment restoring lung volume and ventilation (CO2 level) in intubated neonate with HFOV? Participants will be applied sigh breaths (HFOV-sigh) during on HFOV. Researchers will compare HFOV-sigh mode to see if CO2 level (before-after intervention).

Detailed description

Sample size calculation (before and after intervention: two dependent mean) * alpha = 0.05, beta = 0.2, * Delta = 1.9, SD. = 4.35 * Calculated sample size = 42 * increase sample size if loss follow up 20% * Final sample size (n) = 50 Subgroup analysis for * preterm neonates * very preterm or very low birth weight neonates * extremely preterm or extremely low birth weight neonates

Interventions

DEVICEHFOV-sigh

HFOV-sigh setting both SLE6000 and Drager Babylog VN500: setting (Hz, MAP, delta pressure) same as HFOV, set sigh RR 3 breath/min, Sigh Ti = 1 sec, Sigh PIP = (MAP+5, maximum 30) cm H2O, Slope sigh 0.5.

Sponsors

Prince of Songkla University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 28 Days
Healthy volunteers
No

Inclusion criteria

* Preterm and term neonate (gestational age 24-41 weeks) with postnatal age less than 28 days * Already ventilated with high frequency ventilation at least 1 hours * An umbilical or peripheral arterial catheterization was available

Exclusion criteria

* Previous or current pulmonary air leaks (pulmonary interstitial emphysema, pneumothorax, pneumomediastinum, and pneumopericardium) * Heterogeneous lung disease including MAS, congenital diaphragmatic hernia * Suspected lung hypoplasia * Suspected or confirmed intraventricular hemorrhage grade III-IV * Suspected or confirmed hypoxic ischemic encephalopathy or 5-min Apgar score less than 3 * Hemodynamic instability despite using inotrope(s) * Arterial pCO2 level less than 45 mm Hg or more than 70 mm Hg before intervention * Need a new arterial puncture for samples both before and after interventions * Moribund status * Parents' decision not to participate

Design outcomes

Primary

MeasureTime frameDescription
Arterial pCO2 Levelbefore sigh (baseline) and after sigh (2 hours)ABL800 BASIC (Radiometer Medical ApS™, Denmark) analyzed all blood gas samples within 1 min after collection. The blood gas machine was auto-calibrated every 4 h by trained specialists every day.

Secondary

MeasureTime frameDescription
Oxygenationbefore sigh (baseline) and after sigh (2 hours)oxygen index (oxygen index = mean airway pressure x FiO2 / PaO2), higher scores mean a worse outcome, no unit of scale.
Mean Airway Pressure2 hours after sigh breathsMean Airway Pressure (MAP), cmH2O

Countries

Thailand

Participant flow

Pre-assignment details

Ninety-four infants were assessed for eligibility; 64 were excluded because of previous or current pulmonary air leaks (n = 3), heterogeneous lung diseases (n = 7), suspected or confirmed grade III-IV intraventricular hemorrhage (n = 1), hemodynamic instability despite using an inotrope (n = 15), PaCO2 level \< 45 or \> 70 mm Hg before intervention (n = 30), moribund status (n = 7), and parents' decision not to participate (n = 1). Thirty participants were finally enrolled.

Participants by arm

ArmCount
HFOV-sigh Mode
HFOV-sigh setting both SLE6000 and Drager Babylog VN500: setting (Hz, MAP, delta pressure) same as HFOV, set sigh RR 3 breath/min, Sigh Ti = 1 sec, Sigh PIP = (MAP+5, maximum 30) cm H2O, Slope sigh 0.5.
30
Total30

Baseline characteristics

CharacteristicHFOV-sigh Mode
Age, Continuous1.88 day
Birth weight2305 grams
STANDARD_DEVIATION 853
Gestational age33.6 weeks
STANDARD_DEVIATION 4.1
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
30 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Sex: Female, Male
Female
13 Participants
Sex: Female, Male
Male
17 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 30
other
Total, other adverse events
0 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Arterial pCO2 Level

ABL800 BASIC (Radiometer Medical ApS™, Denmark) analyzed all blood gas samples within 1 min after collection. The blood gas machine was auto-calibrated every 4 h by trained specialists every day.

Time frame: before sigh (baseline) and after sigh (2 hours)

ArmMeasureGroupValue (MEAN)Dispersion
HFOV-sigh ModeArterial pCO2 LevelHFOV before sigh48.8 mm HgStandard Deviation 3.1
HFOV-sigh ModeArterial pCO2 LevelHFOV after sigh45.2 mm HgStandard Deviation 6.6
Secondary

Mean Airway Pressure

Mean Airway Pressure (MAP), cmH2O

Time frame: 2 hours after sigh breaths

Population: the frequency of each MAP level was presented by the count of participants

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
HFOV-sigh ModeMean Airway PressureMAP = 7 cmH2O5 Participants
HFOV-sigh ModeMean Airway PressureMAP = 8 cmH2O12 Participants
HFOV-sigh ModeMean Airway PressureMAP = 9 cmH2O8 Participants
HFOV-sigh ModeMean Airway PressureMAP = 10 cmH2O4 Participants
HFOV-sigh ModeMean Airway PressureMAP = 13 cmH2O1 Participants
Secondary

Oxygenation

oxygen index (oxygen index = mean airway pressure x FiO2 / PaO2), higher scores mean a worse outcome, no unit of scale.

Time frame: before sigh (baseline) and after sigh (2 hours)

Population: oxygen index = mean airway pressure x FiO2 / PaO2

ArmMeasureGroupValue (MEDIAN)
HFOV-sigh ModeOxygenationHFOV before sigh3.06 no unit
HFOV-sigh ModeOxygenationHFOV after sigh2.95 no unit

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026